- Home
- ZLAB vs LBTYB Comparison
ZLAB vs LBTYB Comparison
Compare ZLAB & LBTYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- LBTYB
- Stock Information
- Founded
- ZLAB 2013
- LBTYB 2004
- Country
- ZLAB China
- LBTYB Bermuda
- Employees
- ZLAB N/A
- LBTYB N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- LBTYB Cable & Other Pay Television Services
- Sector
- ZLAB Health Care
- LBTYB Telecommunications
- Exchange
- ZLAB Nasdaq
- LBTYB Nasdaq
- Market Cap
- ZLAB 3.5B
- LBTYB 3.7B
- IPO Year
- ZLAB 2017
- LBTYB N/A
- Fundamental
- Price
- ZLAB $29.24
- LBTYB $9.54
- Analyst Decision
- ZLAB Buy
- LBTYB
- Analyst Count
- ZLAB 4
- LBTYB 0
- Target Price
- ZLAB $47.37
- LBTYB N/A
- AVG Volume (30 Days)
- ZLAB 1.2M
- LBTYB 701.0
- Earning Date
- ZLAB 05-08-2025
- LBTYB 01-01-0001
- Dividend Yield
- ZLAB N/A
- LBTYB N/A
- EPS Growth
- ZLAB N/A
- LBTYB N/A
- EPS
- ZLAB N/A
- LBTYB N/A
- Revenue
- ZLAB $418,326,000.00
- LBTYB $4,421,800,000.00
- Revenue This Year
- ZLAB $44.43
- LBTYB $4.47
- Revenue Next Year
- ZLAB $48.68
- LBTYB N/A
- P/E Ratio
- ZLAB N/A
- LBTYB N/A
- Revenue Growth
- ZLAB 43.72
- LBTYB 32.44
- 52 Week Low
- ZLAB $15.65
- LBTYB $9.20
- 52 Week High
- ZLAB $39.77
- LBTYB $21.90
- Technical
- Relative Strength Index (RSI)
- ZLAB 42.71
- LBTYB 34.81
- Support Level
- ZLAB $27.61
- LBTYB $9.20
- Resistance Level
- ZLAB $32.02
- LBTYB $9.54
- Average True Range (ATR)
- ZLAB 1.23
- LBTYB 0.19
- MACD
- ZLAB -0.18
- LBTYB -0.10
- Stochastic Oscillator
- ZLAB 23.41
- LBTYB 16.43
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About LBTYB Liberty Global Ltd. Class B
Liberty Global is a holding company with interests in several telecom companies in the UK, the Netherlands, Belgium, Switzerland, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies, and has pursued a strategy since 2016 to merge or partner with mobile-network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.